Meperidine Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Meperidine Drugs Market is Segmented By Route of Administration (Oral, Parenteral), Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, De-addiction) and Geography.

Meperidine Drugs Market Snapshot

Meperidine Drugs Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global meperidine drugs market size is expected to grow at a CAGR of 4.1% over the forecast period. Increasing prevalence of diseases that cause chronic pain, such as cancer, periodontal disorders, postsurgical pain, lower back pain, fibromyalgia, and arthritis, is driving the market. As per the study of “Postoperative Pain Control”, around 75 percent of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity which further bolster the overall growth.

A key trend observed in the market is a significant rise in geriatric population, on the heels of increasing demand for pain relief solutions. This trend is likely to continue positively influencing the demand for meperidine drugs. Growing demand of meperidine drugs is driven by the cost efficiency of OTC analgesics drugs, technological advancement in the field of drug delivery systems, and increasing awareness amongst patients.

The wide range of application posses high probability to provide lucrative growth opportunities to meperidine drugs market. Some of the applications includes headache, muscle strain, bruising, or arthritis for recovering the modest pain. However, meperidine abuse, dependency and side effects of drugs may restrict the market.

Scope of the Report

As per the scope of the report, meperidine is a narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. Meperidine drug market is segmented by route of administration, application and geography.

By Route Of Administration
By Application
Pain Relief
Cough Suppression
Diarrhea Suppression
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Anesthesia Segment is Expected to Show the Highest CAGR And is Expected to Continue the Same during the Forecast Period

  • Anesthesia are expected to grow at a lucrative CAGR during the forecast period. There has been an increase in number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries. This is a major factor driving the market for anesthetic segment. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise.
  • The high growth potential attained is a consequence of aging population with chronic diseases. The positive patient outcomes can be attributed to significant improvements in post-operative pain relief.
  • In addition, the pain relief segment is anticipated to grow rapidly in the market mainly due to high usage of the drug in pain management therapies. However, product usage for pain is expected to decline over the forecast period owing to implementation of new regulatory framework. A new guideline has been designed by the CDC for Prescribing meperidine for Chronic Pain.
Meperidine Drugs Market

The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America held the largest share in the market owing to the significant number of surgical procedures performed in the U.S. Increasing incidence of pain and pain-related disorders coupled with the escalating prevalence of chronic disorders are among factors driving the market in this region. This has been adding to healthcare expenditures of the nations in the region. Incremental rise in the number of patients and increasing product cognizance & adoption has also been accelerating market growth in the region. 

The Asia-Pacific is expected to witness the fastest growth over the forecast period. The growth is attributed to increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of meperidine in post-operative pain management. Moreover, expanding geriatric population, is anticipated to drive the number of surgical procedures performed in the region, thereby promising the growth over the forecast period.

Meperidine Drugs Market

Competitive Landscape

The meperidine drugs market is moderately competitive and consists of selective number of major players. Investment for the development of effective & long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaboration are the key strategies adopted by the companies to increase their market share.

The major players include companies such Sanofi Aventis, Mallinckrodt Pharmaceuticals, Pfizer Inc., Epic Pharma, Novartis (Sandoz Canada Inc.), Sun Pharmaceutical, VINTAGE PHARMS and Teva Pharmaceutical.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Expanding Application of Meperidine in Various Therapeutic Conditions

      2. 4.2.2 Rising Prevalnce of Chronic Pain & Infectious Disease

    3. 4.3 Market Restraints

      1. 4.3.1 Meperidine Abuse and Dependency

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Route Of Administration

      1. 5.1.1 Oral

      2. 5.1.2 Parenteral

    2. 5.2 By Application

      1. 5.2.1 Pain Relief

      2. 5.2.2 Anesthesia

      3. 5.2.3 Cough Suppression

      4. 5.2.4 Diarrhea Suppression

      5. 5.2.5 De-addiction

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Rest of the World


    1. 6.1 Company Profiles

      1. 6.1.1 Epic Pharma

      2. 6.1.2 Mallinckrodt Pharmaceuticals

      3. 6.1.3 Pfizer Inc.

      4. 6.1.4 Novartis (Sandoz Canada Inc.)

      5. 6.1.5 Sanofi Aventis

      6. 6.1.6 Sun Pharmaceutical

      7. 6.1.7 Teva Pharmaceutical

      8. 6.1.8 Vintage Pharms

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Meperidine Drugs Market market is studied from 2018 - 2026.

The Meperidine Drugs Market is growing at a CAGR of 4.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Sanofi Aventis , Mallinckrodt Pharmaceuticals, Pfizer Inc, Novartis (Sandoz Canada Inc.) , Epic Pharma are the major companies operating in Meperidine Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!